PFIZER Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > pfizer

Technical Analysis

Technical Strength: 2.1 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 38.9. According to RSI analysis, pfizer is weak. 3.0 PFIZER RSI Chart
MACD (?) MACD: -18.1 and Signal Line: -13.6. According to MACD analysis, pfizer is technically weak. 2.0 PFIZER MACD Chart
Simple Moving Average (?) According to simple moving average analysis, pfizer is in a downtrend. Resistance level is at 1.75e+03. 1.0 PFIZER Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, pfizer is in a strong downtrend. Major resistance levels are 1751.979, 1771.618, 1794.749. 0.0 PFIZER Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.175. According to bollinger bands, pfizer is technically weak. 3.0 PFIZER Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is below all levels. Resistance levels are 1748.996 and 1770.0. Support level is 1681.0. 2.5 PFIZER Fibonacci Retracement Chart
Average True Range (?) ATR: 43.8 NA PFIZER Average True Range Chart
Average Directional Index (?) ADX is 22 which means PFIZER is in a trading range and there is no trend. NA PFIZER Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
October 19, 2017
Open Price 1718.05
High Price 1725.0
Low Price 1712.7
Close Price 1722.15
Absolute Change 2.85
Percentage Change 0.166%
Weekly Change -0.029%
Monthly Change -2.72%
Yearly Change -7.98%
52-week high 1957.0
52-week low 1642.0
Corporate Actions
ExDate Purpose
August 22, 2017 DIV-RS 15+SPL DIV-RS 5
June 27, 2016 DIV-RS.15 PER SHARE
July 03, 2015 AGM/DIV-RS.12.50 PR SHR
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.292
Confidence in Beta0.666%
Market Capital Rs. 7878.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 48.7
TTM Price-to-Earnings (P/E) Ratio 35.4
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 19 October 2017: Deliverable Quantity:1.02e+03 NA PFIZER Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 19 October 2017: Daily Volatility:0.1949 NA PFIZER Annualized Daily Volatility (Spot Price) Chart


October 11, 2017 PfizPress Releasezer Limited has informed the Exchange regarding a press release dated October 10, 2017, titled "Press Release by Pfizer Inc., USA - Pfizer reviewing strategic alternatives for Consumer Healthcare Business".
September 07, 2017 PfizAnalysts/Institutional Investor Meet/Con. Call Updateszer Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
See all Announcements

Board Meetings

Date Meeting Date Purpose
July 20, 2017 July 29, 2017 intResultster alia, to consider and take on record the Unaudited Financial Results of the Company for the first quarter ended June 30, 2017.
April 27, 2017 May 06, 2017 inteResults/Dividender alia, to consider and take on record the Audited Financial Results of the Company for the quarter January 1, 2017 to March 31, 2017 and for the financial year ended March 31, 2017. At the said meeting, the Board of Directors will also consider recommendation of dividend, if any, for the financial year ended March 31, 2017. Further that the Trading Window for trading in the Equity shares of the Company will be closed from April 27, 2017 to May 8, 2017, both days inclusive.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 1703 Rs. 1708 Rs. 1715 Rs. 1720 Rs. 1727 Rs. 1732 Rs. 1740